尼古丁通过抑制NLRP3和改变肠道微生物群来改善DSS诱导的大肠炎
Yi-Xiang Zhang1, Xiao-Qian Chi1, Meng Li2
1Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100050, China.
Journal of Asian natural products research
|April 24, 2024
概括
尼古丁可以通过恢复肠道细菌和减少炎症来帮助治疗性结肠炎 (UC). 这项研究表明,尼古丁抑制了NLRP3炎症酶组合,降低了UC小鼠中的IL-1β分泌.
科学领域:
- 胃肠病学 胃肠病学
- 免疫学 免疫学 免疫学
- 微生物学 微生物学
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病.
- 吸烟在流行病学上与UC风险降低有关.
- 肠道疾病和炎症是UC的关键特征.
研究的目的:
- 在性结肠炎的小鼠模型中研究尼古丁的治疗潜力.
- 探索尼古丁对肠道微生物群和炎症通路的影响.
主要方法:
- 利用大肠炎的小鼠模型来评估尼古丁的影响.
- 进行了体内和体外实验,以分析微生物群组成和炎症标志物.
- 研究了尼古丁对NLRP3炎症酶组合和IL-1β分泌的影响.
主要成果:
- 尼古丁的使用改善了UC小鼠的结肠炎症状.
- 尼古丁调节了结肠微生物群,促进有益的细菌,抑制有害的细菌.
- 尼古丁抑制了NLRP3炎症酶组合,导致IL-1β分泌减少.
结论:
- 尼古丁显示出治疗性结肠炎的治疗潜力.
- 尼古丁的保护作用可能源于其调节肠道微生物群和抑制NLRP3介导炎症的能力.
相关概念视频
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
193
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
193
Drugs for Treatment of Diarrhea-Predominant IBS
161
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
161
CNS Depressants: Alcohol and Nicotine
205
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
205
Drugs for Treatment of Ulcerative Colitis in IBD
138
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
138


